πŸ‡ΊπŸ‡Έ FDA
Patent

US 8557844

Substrate reduction therapy

granted A61KA61K31/195A61K31/197

Quick answer

US patent 8557844 (Substrate reduction therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/195, A61K31/197, A61K31/40, A61K31/42